Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Rong Fan(Vrije Universiteit Brussel), Kim De Veirman(Vrije Universiteit Brussel)

Journal for ImmunoTherapy of Cancer

January 1, 2023

10.1136/jitc-2022-005319

Cited by 19

Related Papers

Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells

|Oncotarget|2015|70

Targeting the β <sub>2</sub> ‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

|The Journal of Pathology|2022|16

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia

|Blood Cancer Journal|2023|15